Aurora Cannabis Rockets on CBD deal to enter the U.S. market

Aurora Cannabis is rocketing this morning on news it struck a deal to enter the U.S. cannabis market after buying CBD company, Reliva.  “It’s immediate access into the world’s largest cannabinoid market,” Aurora Executive Chairman and interim CEO Michael Singer, as quoted by CNBC. “I think the Reliva acquisition is a responsible strategic entry into the … Continue reading Aurora Cannabis Rockets on CBD deal to enter the U.S. market

Telehealth Boom Could Create $175 Billion Opportunity by 2026

With the coronavirus making its rounds, telemedicine is under big demand. All as government and health officials advise against face to face meetings.  It’s becoming so popular Global Market Insights estimates the market could be worth $175 billion by 2026. Markets and Markets estimates telehealth could grow from $25.4 billion in 2020 to more than … Continue reading Telehealth Boom Could Create $175 Billion Opportunity by 2026

The Top 3 Moments from the Berkshire Hathaway Meeting

“Nothing can stop America.” That was Warren Buffett’s firm message at Berskshire’s 2020 annual shareholder meeting. Some of the key highlights at the meeting included: “Nothing can stop America” “The American miracle, the American magic has always prevailed, and it will do so again. … In World War II, I was convinced of this,” he … Continue reading The Top 3 Moments from the Berkshire Hathaway Meeting

Moderna (MRNA) Advances to Next Stage of Vaccine Testing

We may be nearing a coronavirus vaccine. Just yesterday, Moderna (MRNA) announced it submitted an Investigational New Drug (IND) application to the US FDA for its mRNA candidate to “evaluate mRNA-1273 in Phase 2 and late-stage studies if supported by safety data from the Phase 1 study led by the National Institute of Allergy and … Continue reading Moderna (MRNA) Advances to Next Stage of Vaccine Testing

IBM Beats Estimates, But Forced to Pull Full-Year Guidance

Shares of IBM slipped in afterhours trading. Not only did it report a pullback in first quarter revenue, in pulled its annual forecast. “Looking at the first quarter, through February we were tracking roughly in-line with our expectations,” said Chief Financial Officer James Kavanaugh as quoted by MarketWatch. “As we got into March, the health … Continue reading IBM Beats Estimates, But Forced to Pull Full-Year Guidance

How to Invest In Small-Cap Stocks For Long-Term Benefits

Small-cap stocks offer several unique advantages to investors over other types of stocks. They often yield high returns due to several factors including the lack of available information. Their growth prospects are literally limitless. However, the liquidity of small-cap stocks is lower, therefore they are subject to more volatility. So, how should you invest in … Continue reading How to Invest In Small-Cap Stocks For Long-Term Benefits

What You Should Know Before Investing In Small-cap Stocks

Small-cap stocks seem to be holding a lot of interesting possibilities in the wake of the prevailing market conditions. Several industry veterans have expressed their interest in these, considering them promising investments. However, if you’re just venturing into the field of small-cap stocks, there are several important things to keep in mind which this article … Continue reading What You Should Know Before Investing In Small-cap Stocks

Small-Cap Companies and Financial Stocks Promising: TradeWise Director

Small-cap companies, as well as financial stocks, look immensely promising at the moment. This is in view of the prevailing market conditions. The market sell-off phenomenon affects small-cap stocks too, even though these are publicly-traded companies with a market capitalization below $2B USD. The group of these small-cap stocks experienced an 11% fall from the … Continue reading Small-Cap Companies and Financial Stocks Promising: TradeWise Director